Theravance Biopharma, Inc. (TBPH)
16.20
-0.06
(-0.37%)
USD |
NASDAQ |
May 19, 12:02
Theravance Biopharma Total Liabilities (Quarterly) : 181.72M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Viatris, Inc. | 22.18B |
| Relmada Therapeutics, Inc. | 16.63M |
| Indivior Pharmaceuticals, Inc. | 1.341B |
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 472.31M |
| Shareholders Equity (Quarterly) | 290.59M |
| Debt to Equity Ratio | 0.2522 |
| Current Ratio | 13.14 |
| Net Debt Paydown Yield | -0.56% |